Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Netanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIBExtra revenues directed to reservesSpecial session at Nine Senses Fest 2026Andrea Bocelli to Perform at 2026 WC OpeningNetanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIBExtra revenues directed to reservesSpecial session at Nine Senses Fest 2026Andrea Bocelli to Perform at 2026 WC Opening
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#nexicart-2

Latest news and interesting information about nexicart-2.

Immix Biopharma Closes $140.65M Stock Offering
2026-05-22 21:33
|
947

Immix Biopharma Closes $140.65M Stock Offering

Immix Biopharma closes $140.65 million stock offering. Company advances AL Amyloidosis treatment with NXC-201.

COMPANY →
0
Immix Biopharma reports 95% complete response rate in trial
2026-05-21 10:24
|
364

Immix Biopharma reports 95% complete response rate in trial

Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.

COMPANY →
0
...